The Chemours Stock Fundamentals
| CC Stock | MXN 408.90 0.00 0.00% |
The Chemours fundamentals help investors to digest information that contributes to Chemours' financial success or failures. It also enables traders to predict the movement of Chemours Stock. The fundamental analysis module provides a way to measure Chemours' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chemours stock.
Chemours |
The Chemours Company Operating Margin Analysis
Chemours' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Chemours Operating Margin | 0.12 % |
Most of Chemours' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, The Chemours is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, The Chemours has an Operating Margin of 0.1167%. This is 107.99% lower than that of the Basic Materials sector and 102.04% lower than that of the Specialty Chemicals industry. The operating margin for all Mexico stocks is 102.12% lower than that of the firm.
Chemours Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Chemours's current stock value. Our valuation model uses many indicators to compare Chemours value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chemours competition to find correlations between indicators driving Chemours's intrinsic value. More Info.The Chemours is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about 0.12 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for The Chemours is roughly 8.09 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Chemours by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Chemours' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Chemours Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chemours' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chemours could also be used in its relative valuation, which is a method of valuing Chemours by comparing valuation metrics of similar companies.Chemours is currently under evaluation in operating margin category among its peers.
Chemours Fundamentals
| Return On Equity | 0.53 | |||
| Return On Asset | 0.0653 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 146.34 B | |||
| Shares Outstanding | 148.5 M | |||
| Shares Owned By Insiders | 1.09 % | |||
| Shares Owned By Institutions | 77.77 % | |||
| Price To Earning | 82.94 X | |||
| Price To Book | 3.61 X | |||
| Price To Sales | 13.34 X | |||
| Revenue | 6.79 B | |||
| Gross Profit | 1.62 B | |||
| EBITDA | 1.2 B | |||
| Net Income | 578 M | |||
| Cash And Equivalents | 697 M | |||
| Cash Per Share | 4.25 X | |||
| Total Debt | 3.59 B | |||
| Debt To Equity | 529.20 % | |||
| Current Ratio | 1.81 X | |||
| Book Value Per Share | 7.45 X | |||
| Cash Flow From Operations | 754 M | |||
| Earnings Per Share | 68.58 X | |||
| Price To Earnings To Growth | 1.71 X | |||
| Number Of Employees | 6.6 K | |||
| Beta | 1.88 | |||
| Market Capitalization | 96.97 B | |||
| Total Asset | 7.64 B | |||
| Z Score | 16.2 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 7.64 B | |||
| Last Dividend Paid | 1.0 |
About Chemours Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze The Chemours's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemours using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The Chemours based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in Mexico and is traded on Mexico Stock Exchange. It employs 7000 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Chemours Stock Analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.